Global Brachytherapy Devices Market Research Report: Forecast (2024-2029)

Market Definition

Brachytherapy is radiation therapy that is used to treat localized tumor cells inside the human body, through the placement of a device nearby tumor tissues. This device emits radiation which only affects the surrounding tumor tissues and allows it to destroy cancer cells. These devices have applications in most cancer diseases including prostate cancer, breast cancer, skin cancer, etc.

Market Insights and Analysis: Global Brachytherapy Devices Market (2024-2029):

The Global Brachytherapy Devices Market is projected to grow at a CAGR of around 7.0% during the forecast period, i.e., 2024-2029. The major factors supporting the growth of the market are; a growing number of cancer cases, and enhancement in technology used in brachytherapy devices. The number of cancer patients has been increasing significantly during historical years, majorly because of an increase in cancer-causing pollutants in the atmosphere, coupled with enhanced penetration of natural UV radiation.

The continuous increase in the number of cancer patients emphasizes the need for accurate and convenient therapeutic devices. Advantages of brachytherapy devices, like localized treatment, and the ability to reach difficult-to-reach locations would uplift their adoption over conventional radiotherapies during 2024-2029.

Further, healthcare physicians, & organizations have also been observed to largely prefer brachytherapy solutions, in comparison to other traditional radiotherapy. It was majorly attributed to the targeting nature of the therapy, as it does not have any side effects on unaffected non-tumor cells.

Hence, as it has been proved to provide accurate and targeted treatments to patients, which has been amplifying its adoption across hospitals globally. Also, the enhanced installation of minimally invasive procedures and its high demand among consumers further supported the growing adoption of brachytherapy devices across healthcare centers globally during historical years.

In cancer therapeutics, drugs are designed to affect the cell cycle mechanism, which can be controlled to inhibit the cell division of the tumor cells. Brachytherapy has been receiving an immense demand among all the available cancer therapeutics, owing to their nature of targeting tumor cells only. Most cancer drugs have been observed to show side effects, including the negative effect of the cell division process of non-tumoral cells. This is not the case in brachytherapy, as it has been found to effectively target the tumoral tissues, thus reducing other side effects caused by conventional drugs.

Moreover, the changing lifestyle of consumers, which has been constantly indicating the rising consumption of unhealthy diets, coupled with the harsh climatic conditions are anticipated to further upscale the number of cancer cases in coming years. For instance,

• In 2021, according to the World Health Organization (WHO), the total number of cancer cases which emerged in 2020 was 19.3 million, and this is projected to increase to 24.6 million by 2030

This rising number of cancer cases would create an opportunity for the growth of the brachytherapy market in the coming years, as radiation therapies have been one of the most preferred treatment solutions among cancer patients.

Global Brachytherapy Devices Market Driver:

Rising Burden of Geriatric Population to Drive the Demand for Brachytherapy – The growing geriatric population globally is much more sensitive to carcinogenic agents, which has been leading to a significant rise in cancer prevalence in the geriatric population. There are various changes in the old-age population that have been responsible for the high rate of cancer like cellular damage, DNA damage, & weakened immune response among others.

Furthermore, the older population is also highly sensitive to the therapies that have been used for cancer treatment, as their tolerance is lower in comparison to the younger population. Hence, these patients have been observed to prefer therapies with lower side effects, and targeted effects, among which brachytherapy is one. Consequently, the growing geriatric population and rising cases of cancer among them have been positively affecting the demand for brachytherapy devices across the globe.

As per World Health Organization, the geriatric population in 2020 was around 1 billion, which would be doubled to 2.1 billion by the end of 2050. Hence, as the life expectancy of the consumers is increasing, which would uplift the geriatric population, and enhance the prevalence of cancer as well across the world. Therefore, this would drive the growth of the Global Brachytherapy Devices Market in the upcoming years.

Global Brachytherapy Devices Market Opportunity:

Enhanced Research on Integration of Artificial Intelligence (AI) in Brachytherapy Devices to Support Market Growth – In recent years, the integration of artificial intelligence in the brachytherapy market has been emerging and companies have been constantly investing in the same. Also, in recent research works, AI algorithms have been observed to analyze medical images, including CT or MRI scans, to support radiologists in optimizing treatment. Further, it also increases the accuracy and consistency of treatment planning. In addition, artificial intelligence algorithms can improve the distribution of radiation therapy in the target area while minimizing the impact on healthy tissue.

Furthermore, these AI models were observed to examine treatment planning data and historical outcomes, proposing enhanced drug delivery strategies to enhance cancer treatment while mitigating the potential for complications. Thus, this approach would facilitate individualized treatment planning and it would improve the overall treatment outcomes. Although, the use of AI in the brachytherapy market has not yet been commercialized, but several companies have already started research on the same. For instance,

• In 2020, Perception Vision Medical Technologies Co. Ltd., in collaboration with Sichuan Cancer Hospital used Artificial Intelligence to perform CTV (clinical target volume) delineation on CT images automatically for interstitial Brachytherapy by applicator. This research has aimed to improve the imaging of brachytherapy devices.

Hence, this improved research on integrating the application of AI in brachytherapy devices would create an opportunity for the growth of the Global Brachytherapy Devices Market in the coming years. 

Global Brachytherapy Devices Market Challenge:

Lack of Trained Professionals for Brachytherapy Devices to Hinder the Market Growth – Brachytherapy devices required skilled experts to operate these devices. Physicians, radiologists, medical physicists, and others involved in brachytherapy need special training to prepare and administer these treatments. Also tasks such as; imaging-guided electronic placement, and treatment planning using advanced software, requires expertise in different domains including the medical field, technology, etc., the training of the physicians is an essential step.

Lack of specialists in some of these areas has limited access to effective brachytherapy services, which has been negatively affecting the growth of the market. It is mainly as complex procedures and the exact location of electronic devices can be challenging for professionals, who have not received specialized training for the same. However, the companies have been taking steps to strengthen brachytherapy training and to increase its availability across all healthcare centers globally. They have also been collaborating with professional organizations, and industry partners to facilitate the development of training methods.

Hence, as more professionals would receive training, it would reduce this gap in the availability of experts to perform these therapies. Consequently, it would help in the further adoption of brachytherapy devices, which would drive market growth in the coming years.

Global Brachytherapy Devices Market Trend:

Collaborations Between Brachytherapy Device Providers Gaining Traction – The Global Brachytherapy Devices Market has been experiencing growth in recent years as there has been an increased number of collaborations between Brachytherapy companies that have been helping in the development of innovative devices, treatment techniques, and research studies. Also, manufacturers collaborate with healthcare providers to understand their specific needs and design devices that meet those requirements. For instance,

• In 2022, Biobot Surgical signed an agreement with BEBIG Medical, to collaborate on a robotic-guided high-dose-rate (HDR) brachytherapy solution for prostate cancer treatment. This collaboration aims to exhibit a commitment to accomplishing medical breakthroughs by introducing robotic-based better therapies.

Hence, these collaborations in the market have been playing a vital role in providing advanced treatment options for cancer patients and are poised for the continued growth of the market in the coming years as well.

Global Brachytherapy Devices Market (2024-2029): Segmentation Analysis

The Global Brachytherapy Devices Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2024-2029 at the global level. According to the analysis, the market has been further classified as:

Based on Product Type:

• Seeds
• Applicators & Afterloaders
• Imaging systems
• Others (Needles, Miniaturized X-Ray Source, etc.)

Brachytherapy applicators have dominated the market through advancements in applicator design, and a focus on delivering precise and targeted radiation therapy to enhance patient outcomes. Multichannel applicators have multiple channels or catheters that allow for the placement of multiple radiation sources within the tumor or target area. These advancements in applicator design over the past few years have been enabling better dose distribution and coverage, especially for irregularly shaped tumors, and have improved treatment precision, patient comfort, and treatment outcomes.

In addition, companies such as Varian and Elekta have been actively involved in developing innovative applicators to improve treatment efficacy and patient outcomes. As companies have been investing in research and development, further advancements in applicator design are expected to improve the usage of brachytherapy treatments in the coming years.

Based on Technique:

• Low Dose Rate (LDR)
• High Dose Rate (HDR)
• Pulse Dose Rate (PDR)

HDR (High-Dose Rate) Brachytherapy has been dominating the market in the past few years and is expected to emerge as a top performer in the market in the coming years as well. HDR brachytherapy has been highly preferred among patients as it allows for shorter treatment times, enhancing patient convenience, and reducing the overall cost of treatment. Further, with advancements in technology and increasing adoption by healthcare providers, HDR brachytherapy is anticipated to witness significant growth and become a leading technique in the Global Brachytherapy Devices Market in forthcoming years as well.

Global Brachytherapy Devices Market (2024-2029): Regional Projections

Geographically, the Global Brachytherapy Devices Market expands across:

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Among them, North America has been a leading region in the Global Brachytherapy Devices Market during the historical years. It has been majorly attributed to the presence of a highly developed healthcare system, with the integration of state-of-the-art hospitals, academic research centers, and medical professionals. This high-end infrastructure and trained professionals have been supporting the adoption and use of Brachytherapy devices across the region.

Further, there have been upcoming favorable reimbursement programs in North America, particularly in the United States, to provide better reimbursement for cancer treatments. Also, with medicare and private surgery insurance, brachytherapy would become an affordable treatment option for patients. This would help the market growth of brachytherapy devices across the region in the coming years as well.

Global Brachytherapy Devices Industry Recent Development:

• 2022: Varian, launched BRAVOS® and GammaMedplus™ iX brachytherapy after loaders, along with a wide range of applicators and brachytherapy treatment planning software tools. It was in line to enhance its product portfolio in the brachytherapy segment.
• 2022: iCAD Inc., announced the successful results of a clinical trial of treatment of recurrent glioblastoma (GBM), under which additional patients have been treated. They also announced that these results expanded the usage of their Xoft® Electronic Brachytherapy (eBx®) System® by customers across the globe.

Gain a Competitive Edge with Our Global Brachytherapy Devices Market Report

1. Global Brachytherapy Devices Market Report by Markntel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps business organizations to gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing business organizations to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Brachytherapy Devices Market Report aids in assessing & mitigating risks associated with entering or operating level in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, business organizations can develop strategies to minimize risks & optimize their operations.